# Latigo Biotherapeutics, Inc. — Form D

Latigo Biotherapeutics, Inc. of THOUSAND OAKS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-13. The offering totals $150.0M, of which $50.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-02-13
- Form: D
- Accession: 0002056611-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $150.0M
- Amount sold: $50.0M
- Remaining: $100.0M
- Investors: 7
- Date of first sale: 2025-01-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-538236

## Issuer

- Name: Latigo Biotherapeutics, Inc.
- CIK: 0002056611
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1300 RANCHO CONEJO BLVD. SUITE 305, THOUSAND OAKS, CA, 91320
- Phone: 805-716-2927

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Nima Farzan | Director | Thousand Oaks, CA |
| Deborah Palestrant | Director | Berkeley, CA |
| Kevin Raidy | Director | Thousand Oaks, CA |
| Beth Seidenberg | Director | South San Francisco, CA |
| Nancy Stagliano | Director | South San Francisco, CA |
| Jim Tananbaum | Director | Thousand Oaks, CA |
| Tim Walbert | Director | Thousand Oaks, CA |
| Nima Farzan | Executive Officer | Thousand Oaks, CA |
| Tim Lugo | Executive Officer | Thousand Oaks, CA |

## More

- [CIK 2056611 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2056611&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002056611-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.